We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $861M
1-Year Est. Return 21.33%
This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
+21.33%
3 Year Est. Return
+86.85%
5 Year Est. Return
+97.02%
10 Year Est. Return
+293.06%
AUM
$3.73B
AUM Growth
+$2.64B
Cap. Flow
+$2.53B
Cap. Flow %
67.74%
Top 10 Hldgs %
38.7%
Holding
2,194
New
1,292
Increased
220
Reduced
173
Closed
481

Sector Composition

Rank Sector Weight
1 Financials 1.16%
2 Communication Services 0.88%
3 Consumer Discretionary 0.79%
4 Technology 0.74%
5 Energy 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXLG icon
1601
Destination XL Group
DXLG
$32.9M
$27K ﹤0.01%
+12,121
New +$24.6K
MR
1602
DELISTED
Montage Resources Corporation Common Stock
MR
$27K ﹤0.01%
743
-1,311
-64% -$47.4K
HEPA
1603
DELISTED
Hepion Pharmaceuticals
HEPA
0
PZG icon
1604
Paramount Gold Nevada
PZG
$90.9M
$26K ﹤0.01%
+19,938
New +$25.4K
SGLY icon
1605
Singularity Future Technology
SGLY
$4.05M
$26K ﹤0.01%
+14
New +$27.2K
BYU
1606
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$26K ﹤0.01%
+15
New +$55.5K
MBAI
1607
Check-Cap
MBAI
$8.04M
$25K ﹤0.01%
+121
New +$37.2K
CRDF icon
1608
Cardiff Oncology
CRDF
$63M
$25K ﹤0.01%
1,134
+798
+238% +$35.3K
EGY icon
1609
Vaalco Energy
EGY
$562M
$25K ﹤0.01%
+36,388
New +$28.4K
MVIS icon
1610
Microvision
MVIS
$84.8M
$25K ﹤0.01%
+15,641
New +$30.1K
SMTS
1611
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$25K ﹤0.01%
+10,094
New +$24.8K
FTEK icon
1612
Fuel Tech
FTEK
$43M
$24K ﹤0.01%
+21,313
New +$21.5K
IRD
1613
Opus Genetics
IRD
$287M
$24K ﹤0.01%
+250
New +$25.4K
ARLZ
1614
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$24K ﹤0.01%
+16,550
New +$27.2K
CATX icon
1615
Perspective Therapeutics
CATX
$327M
$23K ﹤0.01%
+5,747
New +$26.8K
GURE
1616
Gulf Resources
GURE
$4.88M
$23K ﹤0.01%
+315
New +$25.3K
LMFA
1617
DELISTED
LM Funding America
LMFA
$23K ﹤0.01%
+2
New +$33.6K
PHIO icon
1618
Phio Pharmaceuticals
PHIO
$11.4M
$23K ﹤0.01%
1
RAVE icon
1619
RAVE Restaurant Group
RAVE
$42.8M
$23K ﹤0.01%
15,776
+1,189
+8% +$1.94K
GNCA
1620
DELISTED
Genocea Biosciences, Inc.
GNCA
$23K ﹤0.01%
+2,430
New +$24.4K
NSPR icon
1621
InspireMD
NSPR
$31.4M
$22K ﹤0.01%
6
+5
+500% +$41.4K
REED
1622
DELISTED
Reeds, Inc. Common Stock
REED
$22K ﹤0.01%
+286
New +$26.1K
APPS icon
1623
Digital Turbine
APPS
$982M
$21K ﹤0.01%
11,606
-10,858
-48% -$17.9K
MBRX icon
1624
Moleculin Biotech
MBRX
$9.61M
$21K ﹤0.01%
+5
New +$21.6K
TRNX
1625
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$21K ﹤0.01%
45
+32
+246% +$19.8K

Similar funds

Two Sigma Securities's Q4 2017 Portfolio in Review

As of Q4 2017, Two Sigma Securities held 2,194 positions worth $3.73B, up 241% from $1.09B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Two Sigma Securities deployed $2.53B of net new capital in Q4 2017, opening 1,292 new positions and adding to 220 existing holdings. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 168,225 shares worth $9.57M.

By sector, the portfolio is most concentrated in Financials at 1.2% of assets, down from 2.3% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $77.5M trimmed.

  • Two Sigma Securities's largest Q4 2017 buy was State Street Consumer Staples Select Sector SPDR ETF: 168,225 shares worth $9.57M.
  • Two Sigma Securities added most to iShares Russell 2000 ETF in Q4 2017, an estimated $73.3M increase.
  • Two Sigma Securities's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $77.5M.
  • Two Sigma Securities fully exited Vanguard Consumer Discretionary ETF in Q4 2017, selling an estimated $22.2M.
  • Two Sigma Securities's ten largest holdings make up 39% of its $3.73B portfolio in Q4 2017.
  • Two Sigma Securities opened 1,292 new positions and closed 481 in Q4 2017.
  • Two Sigma Securities's portfolio value rose 241% quarter-over-quarter to $3.73B.

Based on Two Sigma Securities's 13F filing for Q4 2017, filed 14 Feb 2018.